Samuel J. Vidal

1.5k total citations
12 papers, 798 citations indexed

About

Samuel J. Vidal is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Samuel J. Vidal has authored 12 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Samuel J. Vidal's work include Cancer Cells and Metastasis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Samuel J. Vidal is often cited by papers focused on Cancer Cells and Metastasis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Samuel J. Vidal collaborates with scholars based in United States, Spain and France. Samuel J. Vidal's co-authors include Josep Domingo‐Domenech, Carlos Cordon‐Cardo, Verónica Rodríguez-Bravo, Matt D. Galsky, S. Aidan Quinn, Janis de la Iglesia-Vicente, Dennis M. Bonal, Elizabeth Charytonowicz, José M. Silva and Mireia Castillo-Martín and has published in prestigious journals such as Cell, Cancer Cell and Oncogene.

In The Last Decade

Samuel J. Vidal

12 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel J. Vidal United States 7 473 308 217 164 73 12 798
Mihaela Chivu‐Economescu Romania 14 463 1.0× 249 0.8× 323 1.5× 202 1.2× 124 1.7× 31 891
Fangyin Zeng China 11 295 0.6× 133 0.4× 170 0.8× 151 0.9× 92 1.3× 25 544
Tze‐Sian Chan Taiwan 11 377 0.8× 276 0.9× 171 0.8× 91 0.6× 83 1.1× 22 627
Wen-Hui Su Taiwan 14 471 1.0× 270 0.9× 315 1.5× 132 0.8× 106 1.5× 23 919
Weijie Ma China 20 919 1.9× 226 0.7× 634 2.9× 152 0.9× 71 1.0× 57 1.3k
Hongxia Li China 14 337 0.7× 126 0.4× 247 1.1× 64 0.4× 62 0.8× 39 575
Nathalie Dugot‐Senant France 13 375 0.8× 119 0.4× 157 0.7× 63 0.4× 50 0.7× 30 670
Misty Shuo Zhang Hong Kong 10 467 1.0× 147 0.5× 283 1.3× 167 1.0× 72 1.0× 13 681
Anatol Oleksijew United States 15 634 1.3× 339 1.1× 57 0.3× 107 0.7× 94 1.3× 22 1.0k

Countries citing papers authored by Samuel J. Vidal

Since Specialization
Citations

This map shows the geographic impact of Samuel J. Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel J. Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel J. Vidal more than expected).

Fields of papers citing papers by Samuel J. Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel J. Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel J. Vidal. The network helps show where Samuel J. Vidal may publish in the future.

Co-authorship network of co-authors of Samuel J. Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel J. Vidal. A scholar is included among the top collaborators of Samuel J. Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel J. Vidal. Samuel J. Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vidal, Samuel J., Ninaad Lasrado, Lisa H. Tostanoski, et al.. (2025). Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines. Cell. 188(24). 6791–6803.e13. 1 indexed citations
2.
Mahrokhian, Shant H., Lisa H. Tostanoski, Samuel J. Vidal, & Dan H. Barouch. (2024). COVID-19 vaccines: Immune correlates and clinical outcomes. Human Vaccines & Immunotherapeutics. 20(1). 2324549–2324549. 7 indexed citations
3.
Vidal, Samuel J., Daniel Sellers, Jingyou Yu, et al.. (2023). Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model. iScience. 26(6). 106963–106963. 7 indexed citations
4.
Aïd, Malika, Samuel J. Vidal, César Piedra-Mora, et al.. (2022). Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques. PLoS Pathogens. 18(4). e1009990–e1009990. 5 indexed citations
5.
Vidal, Samuel J., Ai‐ris Y. Collier, Jingyou Yu, et al.. (2021). Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. Journal of Virology. 95(14). e0040421–e0040421. 24 indexed citations
6.
Richterman, Aaron, Samuel J. Vidal, Zoe Weiss, et al.. (2020). Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series. Open Forum Infectious Diseases. 7(10). 32 indexed citations
7.
Tasci, Emre S., Luis Elcoro, Samuel J. Vidal, et al.. (2017). Crystallography online by the Bilbao Crystallographic Server. Acta Crystallographica Section A Foundations and Advances. 73(a2). C137–C137. 3 indexed citations
8.
Tovar, Victoria, Helena Cornellà, Agrin Moeini, et al.. (2015). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut. 66(3). 530–540. 160 indexed citations
9.
Vidal, Samuel J., S. Aidan Quinn, Janis de la Iglesia-Vicente, et al.. (2014). Isolation of Cancer Stem Cells From Human Prostate Cancer Samples. Journal of Visualized Experiments. 5 indexed citations
10.
Vidal, Samuel J., S. Aidan Quinn, Janis de la Iglesia-Vicente, et al.. (2014). Isolation of Cancer Stem Cells From Human Prostate Cancer Samples. Journal of Visualized Experiments. 1 indexed citations
11.
Vidal, Samuel J., Verónica Rodríguez-Bravo, Matt D. Galsky, Carlos Cordon‐Cardo, & Josep Domingo‐Domenech. (2013). Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene. 33(36). 4451–4463. 215 indexed citations
12.
Domingo‐Domenech, Josep, Samuel J. Vidal, Verónica Rodríguez-Bravo, et al.. (2012). Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells. Cancer Cell. 22(3). 373–388. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026